Literature DB >> 11746688

Structural determinants of binding and specificity in transforming growth factor-receptor interactions.

P K Shah1, C M Buslje, R Sowdhamini.   

Abstract

Transforming growth factor (TGF-beta) protein families are cytokines that occur as a large number of homologous proteins. Three major subgroups of these proteins with marked specificities for their receptors have been found-TGF-beta, activin/inhibin, and bone morphogenic protein. Although structural information is available for some members of the TGF-beta family of ligands and receptors, very little is known about the way these growth factors interact with the extracellular domains of their cell surface receptors, especially the type II receptor. In addition, the elements that are the determinants of binding and specificity of the ligands are poorly understood. The structure of the extracellular domain of the receptor is a three-finger fold similar to some toxin structures. Amino acid exchanges between multiply aligned homologous sequences of type II receptors point to a residue at the surface, specifically finger 1, as the determinant of ligand specificity and complex formation. The "knuckle" epitope of ligands was predicted to be the surface that interacts with the type II receptor. The residues on strands beta2, beta3, beta7, beta8 and the loop region joining beta2 and beta3 and joining beta7 and beta8 of the ligands were identified as determinants of binding and specificity. These results are supported by studies on the docking of the type II receptor to the ligand dimer-type I receptor complex. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11746688     DOI: 10.1002/prot.10010

Source DB:  PubMed          Journal:  Proteins        ISSN: 0887-3585


  5 in total

1.  The immunomodulator FTY720 and its phosphorylated derivative activate the Smad signalling cascade and upregulate connective tissue growth factor and collagen type IV expression in renal mesangial cells.

Authors:  Cuiyan Xin; Shuyu Ren; Wolfgang Eberhardt; Josef Pfeilschifter; Andrea Huwiler
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

2.  Structural distinctions in BMPs underlie divergent signaling in spinal neurons.

Authors:  Jeanette C Perron; Jane Dodd
Journal:  Neural Dev       Date:  2012-05-04       Impact factor: 3.800

3.  In silico panning for a non-competitive peptide inhibitor.

Authors:  Yukiko Yagi; Kotaro Terada; Takahisa Noma; Kazunori Ikebukuro; Koji Sode
Journal:  BMC Bioinformatics       Date:  2007-01-12       Impact factor: 3.169

4.  Chemotropic signaling by BMP7 requires selective interaction at a key residue in ActRIIA.

Authors:  Jeanette C Perron; Alcina A Rodrigues; Nirupama Surubholta; Jane Dodd
Journal:  Biol Open       Date:  2019-07-16       Impact factor: 2.422

5.  ActRIIA and BMPRII Type II BMP receptor subunits selectively required for Smad4-independent BMP7-evoked chemotaxis.

Authors:  Jeanette C Perron; Jane Dodd
Journal:  PLoS One       Date:  2009-12-08       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.